Michael Thomas
Contributor since: 2012
Pfizer: New CEO, New Strategy, New Focus On Brand Name Drugs In A Year Of Drastic Change
UnitedHealth Group: Strong Year-End Finish Is Quickly Closing The Buying Window
Why I Am Dipping Into Defined Maturity ETFs
Flexsteel Industries: Yield Over 4.70% Is Worth A Look
Hyster-Yale Needs A Lift For Its Shares
Kingstone Companies Presents 4% Yield After Hitting A 'Pothole'
Altria: Still A Long Term Buy
Trawling Tobacco For Income, Finding 10% Annualized Yield
AbbVie: Generate 13% Annualized Yield On This Drug Maker
PepsiCo: Better Than Coca-Cola At Everything (Almost)
The Coca-Cola Company: Solid Dividend, Anemic Growth, And High Valuation
Is Costco Overvalued?
Will British American Come Back To The Table With A Higher Offer?
Altria's Potential New Growth Driver
Imperial Brands: Battered And Bloodied But Not Down For The Count
Current Quarter Is Key For McDonald's
Sleep Well At Night With This Dividend Champion
Big Tobacco Is Smoking The Market - Is There Any Value Left?
You Say Compounding, I Say Yes Please
Why Negative U.S. Treasury Yields Might Become A New Normal
Income Inequality And The Search For Yield
The Most Boring Stock Portfolio On Earth
Daktronics Stock Is Depressing But It's Not All Bad
Verizon Is Well Positioned To Lead The U.S. Mobile Market
Michael Kors: An Unfashionable Portfolio Accessory
Dividend Champion Altria: Attractive Buy With Limited Downside
Discover Shares Look Ripe For Picking
Keying On Cash Return To Build A Growth Portfolio
Pepsi Edges Out Coca-Cola In Key Dividend Growth Measures
Investing In The Business Of War
Finding Dividend Growth In Financials
Target, Time To Buy For A Dividend Growth Investor